Search results for: Vaccines
Filter search results
Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine
1 April 2020
…commercial risk. Vaccines that make it to market may be inferior to others that potentially could have been developed because of push funders ‘picking winners’ from the early prospects, before…
The 2020 OHE Annual Lecture Explores the Question: How Should the World Pay for a COVID-19 Vaccine?
25 June 2020
…to get leading vaccine candidates through clinical trials, there are two further major challenges – manufacturing and delivering COVID-19 vaccines, and ensuring that more candidates are able to enter clinical…
Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic
20 October 2022, 3:00pm
…Moderna and Former Senior Expert Policy & Strategy Adviser at the heart of the COVID-19 pandemic for the UK Government on the UK Vaccines Taskforce, Antiviral Taskforce and Therapeutic Taskforce…
Analysing Global Immunisation Expenditure
15 April 2025
…vaccines to susceptible populations to prevent the spread of infectious diseases. Key takeaways On average, the countries in focus spend 0.08% of their GDP on immunisation, and less than 1%…
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
…on adult immunisation in mostly high and middle income shows that adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the…
Drugs and Vaccines for Developing Countries
1 June 2011
…and initiatives, then, is essential to understanding which policies and programs work well and which do not. Towse, A., Keuffel, E., Kettler, H.E. and Ridley, D.B. Drugs and vaccines for developing…
How Should the World Pay for a COVID-19 Vaccine?
31 July 2020
…ago with a number of vaccines now already progressing through clinical trials, and over a hundred candidates in pre-clinical development. Yet how successful vaccines are to be financed and paid…
The broader economic benefits of COVID-19 vaccination
13 October 2025
…in COVID-19 vaccines is not just a health need, it’s an economic imperative. Vaccines help protect societies and reduce pressure on healthcare systems, while supporting economic stability by keeping people…
OHE submission to the UK Parliamentary Inquiry on an Ageing Society
20 May 2025
…IFPMA, looking at four adult vaccines (against influenza, pneumococcal disease, respiratory syncytial virus (RSV), and herpes zoster (shingles)) across across ten countries that represent a range of healthcare systems, demographics,…